explore -WSS

explore

author：entertainment 2025-09-30 16:23:19 - browse：9487

This is the inaugural edition of Adam’s Biotech Scorecard, a new subscriber-only newsletter. STAT+ subscribers can sign up here to get it delivered every Thursday to their inbox.

Hello! Welcome to the premiere issue of Adam’s Biotech Scorecard. I’m excited to get started. Let’s do this! (By the way, the AF in the logo are my initials, not the “other” AF.)

The contrarian view of Viking Therapeutics

Closeup financial chart

The developer of a dual-acting GLP-1/GIP treatment for obesity is riding high on positive data and takeout speculation. The drug, called VK2735, has shown impressive weight loss with minimal gastrointestinal side effects in both subcutaneous and oral formulations, positioning it as a strong challenger to the obesity juggernauts from Eli Lilly and Novo Nordisk. With a stock price that has soared nearly 800% over the past year, Viking is now a $9 billion company and a prime acquisition target for a cash-rich pharma company.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medical records are filled with copy
Next article： How the BIOSECURE Act is already affecting U.S., Chinese life science firms

WSS

STAT Virtual Event: ASCO Recap, Live!

Medical device trials still don't enroll enough women, study finds

Correcting Robert F. Kennedy Jr.'s vaccine 'facts'

A public health expert passes on football's full body collisions for youths

Science's Marcia McNutt, trailblazer for women, encounters sexism scandal

FDA reviewers ask if approval of Lilly’s Alzheimer’s drug should be restricted

leisure time

explore

The contrarian view of Viking Therapeutics

leisure time

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Biogen nominates mother of director’s child to replace him on board

Continuity nursing helped my family in our darkest PICU moments

Mom launches Girl Scout troop for LGBTQ youth in Texas

In age of alternative facts, a scholarly course on calling out crap

Lilly's Alzheimer's drug donanemab backed by FDA advisers

What does generative AI mean for health care? We asked experts

Mom launches Girl Scout troop for LGBTQ youth in Texas

Continuity nursing helped my family in our darkest PICU moments

Study: Why relieving medical debt did not improve financial outcomes

explore

Curing rare childhood diseases will falter unless Congress steps up

Coercive sterilizations revealed by STAT prompt outrage

STAT Virtual Event: ASCO Recap, Live!

A public health expert passes on football's full body collisions for youths

Over 1,300 arrested in France in 4th night of protests over fatal police shooting of teen Nahel M.

Coercive sterilizations revealed by STAT prompt outrage

explore

knowledge

focus

knowledge